• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期糖基化终产物在阿尔茨海默病中促成淀粉样变性。

Advanced glycation end products contribute to amyloidosis in Alzheimer disease.

作者信息

Vitek M P, Bhattacharya K, Glendening J M, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A

机构信息

Picower Institute for Medical Research, Manhasset, NY 11030.

出版信息

Proc Natl Acad Sci U S A. 1994 May 24;91(11):4766-70. doi: 10.1073/pnas.91.11.4766.

DOI:10.1073/pnas.91.11.4766
PMID:8197133
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC43869/
Abstract

Alzheimer disease (AD) is characterized by deposits of an aggregated 42-amino-acid beta-amyloid peptide (beta AP) in the brain and cerebrovasculature. After a concentration-dependent lag period during in vitro incubations, soluble preparations of synthetic beta AP slowly form fibrillar aggregates that resemble natural amyloid and are measurable by sedimentation and thioflavin T-based fluorescence. Aggregation of soluble beta AP in these in vitro assays is enhanced by addition of small amounts of pre-aggregated beta-amyloid "seed" material. We also have prepared these seeds by using a naturally occurring reaction between glucose and protein amino groups resulting in the formation of advanced "glycosylation" end products (AGEs) which chemically crosslink proteins. AGE-modified beta AP-nucleation seeds further accelerated aggregation of soluble beta AP compared to non-modified "seed" material. Over time, nonenzymatic advanced glycation also results in the gradual accumulation of a set of posttranslational covalent adducts on long-lived proteins in vivo. In a standardized competitive ELISA, plaque fractions of AD brains were found to contain about 3-fold more AGE adducts per mg of protein than preparations from healthy, age-matched controls. These results suggest that the in vivo half-life of beta-amyloid is prolonged in AD, resulting in greater accumulation of AGE modifications which in turn may act to promote accumulation of additional amyloid.

摘要

阿尔茨海默病(AD)的特征是大脑和脑血管系统中存在由42个氨基酸组成的β-淀粉样肽(β-AP)聚集体沉积。在体外孵育过程中经过浓度依赖性的延迟期后,合成β-AP的可溶性制剂会缓慢形成类似于天然淀粉样蛋白的纤维状聚集体,可通过沉降和硫黄素T荧光法进行检测。在这些体外试验中,添加少量预聚集的β-淀粉样“种子”物质可增强可溶性β-AP的聚集。我们还通过利用葡萄糖与蛋白质氨基之间的天然反应制备了这些种子,该反应导致形成可化学交联蛋白质的晚期“糖基化”终产物(AGEs)。与未修饰的“种子”物质相比,AGE修饰的β-AP成核种子进一步加速了可溶性β-AP的聚集。随着时间的推移,非酶促晚期糖基化还会导致体内长寿蛋白质上一组翻译后共价加合物的逐渐积累。在标准化的竞争性酶联免疫吸附测定(ELISA)中,发现AD脑的斑块部分每毫克蛋白质中含有的AGE加合物比来自健康的、年龄匹配的对照的制剂多约3倍。这些结果表明,β-淀粉样蛋白在AD中的体内半衰期延长,导致AGE修饰的积累增加,这反过来可能会促进更多淀粉样蛋白的积累。

相似文献

1
Advanced glycation end products contribute to amyloidosis in Alzheimer disease.晚期糖基化终产物在阿尔茨海默病中促成淀粉样变性。
Proc Natl Acad Sci U S A. 1994 May 24;91(11):4766-70. doi: 10.1073/pnas.91.11.4766.
2
Advanced glycation end product-modified beta2-microglobulin is a component of amyloid fibrils of primary localized cutaneous nodular amyloidosis.晚期糖基化终末产物修饰的β2微球蛋白是原发性局限性皮肤结节性淀粉样变淀粉样纤维的一个组成部分。
J Invest Dermatol. 2002 Mar;118(3):479-84. doi: 10.1046/j.0022-202x.2001.01695.x.
3
Transition metal-mediated glycoxidation accelerates cross-linking of beta-amyloid peptide.过渡金属介导的糖氧化作用加速了β-淀粉样肽的交联。
Eur J Biochem. 2000 Jul;267(13):4171-8. doi: 10.1046/j.1432-1327.2000.01452.x.
4
Advanced glycation end products and receptor for advanced glycation end products in AA amyloidosis.晚期糖基化终末产物及AA型淀粉样变性中的晚期糖基化终末产物受体
Am J Pathol. 2003 Apr;162(4):1213-20. doi: 10.1016/S0002-9440(10)63917-X.
5
Oxidative stress and amyloidosis.氧化应激与淀粉样变性
Histol Histopathol. 1998 Jul;13(3):845-50. doi: 10.14670/HH-13.845.
6
Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.正常衰老和脑淀粉样血管病中的脑淀粉样蛋白在抗原性上与阿尔茨海默病β蛋白相关。
Am J Pathol. 1987 Dec;129(3):422-8.
7
Trans-Synaptic Spread of Amyloid- in Alzheimer's Disease: Paths to -Amyloidosis.阿尔茨海默病中淀粉样蛋白的跨突触传播:淀粉样变性的途径。
Neural Plast. 2017;2017:5281829. doi: 10.1155/2017/5281829. Epub 2017 Dec 24.
8
New aspects in the pathogenesis of dialysis-related amyloidosis: pathophysiology of advanced glycation end products in renal failure.透析相关性淀粉样变发病机制的新进展:肾衰竭中晚期糖基化终产物的病理生理学
Nihon Jinzo Gakkai Shi. 1996 May;38(5):191-7.
9
Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.酪氨酸 10 的硝化作用显著增强了淀粉样 β 的聚集和斑块形成。
Neuron. 2011 Sep 8;71(5):833-44. doi: 10.1016/j.neuron.2011.07.001.
10
beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.经晚期糖基化终末产物修饰的β2-微球蛋白是血液透析相关淀粉样变的主要成分。
J Clin Invest. 1993 Sep;92(3):1243-52. doi: 10.1172/JCI116696.

引用本文的文献

1
Microglial activation states and their implications for Alzheimer's Disease.小胶质细胞激活状态及其对阿尔茨海默病的影响。
J Prev Alzheimers Dis. 2025 Jan;12(1):100013. doi: 10.1016/j.tjpad.2024.100013. Epub 2025 Jan 1.
2
Non-enzymatic posttranslational protein modifications in protein aggregation and neurodegenerative diseases.蛋白质聚集和神经退行性疾病中的非酶促翻译后蛋白质修饰
RSC Chem Biol. 2024 Dec 19;6(2):129-149. doi: 10.1039/d4cb00221k. eCollection 2025 Feb 5.
3
Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer's Pathogenesis.阿尔茨海默病发病机制中β淀粉样蛋白种类的形态学和分子特征分析
Mol Neurobiol. 2025 Apr;62(4):4391-4419. doi: 10.1007/s12035-024-04543-4. Epub 2024 Oct 24.
4
Peptide-Bound Glycative, AGE and Oxidative Modifications as Biomarkers for the Diagnosis of Alzheimer's Disease-A Feasibility Study.肽结合糖基化、晚期糖基化终末产物及氧化修饰作为阿尔茨海默病诊断生物标志物的可行性研究
Biomedicines. 2024 Sep 19;12(9):2127. doi: 10.3390/biomedicines12092127.
5
The alteration and role of glycoconjugates in Alzheimer's disease.糖缀合物在阿尔茨海默病中的改变及作用
Front Aging Neurosci. 2024 Jun 13;16:1398641. doi: 10.3389/fnagi.2024.1398641. eCollection 2024.
6
Alzheimer's disease and its treatment-yesterday, today, and tomorrow.阿尔茨海默病及其治疗——昨天、今天和明天。
Front Pharmacol. 2024 May 24;15:1399121. doi: 10.3389/fphar.2024.1399121. eCollection 2024.
7
Comparison of Eating Habits, Body Composition and Densitometric Parameters between Subjects with Normal Cognitive Function and Mild Cognitive Impairment: An Observational Study.正常认知功能与轻度认知障碍受试者的饮食习惯、身体成分和骨密度参数比较:一项观察性研究。
Nutrients. 2024 Feb 25;16(5):644. doi: 10.3390/nu16050644.
8
Pharmacological Approaches Using Diabetic Drugs Repurposed for Alzheimer's Disease.使用用于阿尔茨海默病的糖尿病药物的药理学方法。
Biomedicines. 2024 Jan 3;12(1):99. doi: 10.3390/biomedicines12010099.
9
Skin autofluorescence, reflecting accumulation of advanced glycation end products, and the risk of dementia in a population-based cohort.皮肤自发荧光,反映了晚期糖基化终产物的积累,以及在基于人群的队列中痴呆的风险。
Sci Rep. 2024 Jan 13;14(1):1256. doi: 10.1038/s41598-024-51703-6.
10
MIF contribution to progressive brain diseases.MIF 对进行性脑部疾病的贡献。
J Neuroinflammation. 2024 Jan 4;21(1):8. doi: 10.1186/s12974-023-02993-6.

本文引用的文献

1
Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?引发淀粉样蛋白的“一维结晶”:阿尔茨海默病和羊瘙痒病的一种致病机制?
Cell. 1993 Jun 18;73(6):1055-8. doi: 10.1016/0092-8674(93)90635-4.
2
The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease.β淀粉样蛋白的羧基末端对淀粉样蛋白形成的种子作用至关重要:对阿尔茨海默病发病机制的启示。
Biochemistry. 1993 May 11;32(18):4693-7. doi: 10.1021/bi00069a001.
3
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state.β-淀粉样肽在体外诱导的神经退行性变:肽组装状态的作用
J Neurosci. 1993 Apr;13(4):1676-87. doi: 10.1523/JNEUROSCI.13-04-01676.1993.
4
Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution.硫黄素T与合成的阿尔茨海默病β-淀粉样肽的相互作用:溶液中淀粉样蛋白聚集的检测。
Protein Sci. 1993 Mar;2(3):404-10. doi: 10.1002/pro.5560020312.
5
Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.β-淀粉样核心蛋白肽主链的结构改变可能是其在阿尔茨海默病中沉积和稳定性的原因。
J Biol Chem. 1993 Feb 15;268(5):3072-83.
6
Release of excess amyloid beta protein from a mutant amyloid beta protein precursor.突变的淀粉样β蛋白前体释放过量淀粉样β蛋白。
Science. 1993 Jan 22;259(5094):514-6. doi: 10.1126/science.8424174.
7
A kinetic model for amyloid formation in the prion diseases: importance of seeding.朊病毒疾病中淀粉样蛋白形成的动力学模型:种子的重要性。
Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):5959-63. doi: 10.1073/pnas.90.13.5959.
8
Glucosylation of human collagen in aging and diabetes mellitus.衰老和糖尿病中人类胶原蛋白的糖基化
J Clin Invest. 1980 Nov;66(5):1179-81. doi: 10.1172/JCI109950.
9
Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus.糖尿病中周围神经蛋白的非酶糖基化
Proc Natl Acad Sci U S A. 1981 Aug;78(8):5190-2. doi: 10.1073/pnas.78.8.5190.
10
Nonenzymatic browning in vivo: possible process for aging of long-lived proteins.体内非酶促褐变:长寿蛋白老化的可能过程。
Science. 1981 Jan 30;211(4481):491-3. doi: 10.1126/science.6779377.